Not Signed In -
Age-Related Macular Degeneration |
AMD |
Listen to this article · (info) This audio file was created from an article revision dated 2005-07-19, and does not reflect subsequent edits to the article. (Audio help) More spoken articles Human eye cross-sectional view. Courtesy NIH National Eye Institute Normal vision. Courtesy NIH National Eye Institute The same view with age-related macular deneneration. Macular degeneration is a medical condition where the light sensing cells in the mac ...
Wikipedia - [full article]
Age-Related Macular Degeneration Clinical Trials
- An evaluation of safety and efficacy of Anecortave Acetate vs. placebo in patients with subfoveal choroidal neovascularization(CNV) due to wet age-related macular degeneration(AMD)
ClinicalTrials.gov Identifier: NCT00051129 - Active, not recruiting
Macular Degeneration; Maculopathy, Age-Related; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related
- Effects of Sun Filters on Age-Related Macular Degeneration in People With Lens Implants
ClinicalTrials.gov Identifier: NCT00487838 - Recruiting
Age-Related Macular Changes; Age-Related Macular Degeneration; Cataract and IOL Surgery; Retinal Photochemistry
- EXCITE - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (ARMD)
ClinicalTrials.gov Identifier: NCT00275821 - Active, not recruiting
Age-Related Macular Degeneration
- Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population
ClinicalTrials.gov Identifier: NCT00533754 - Active, not recruiting
Age-Related Macular Degeneration
- A Trial to Assess the Safety and Tolerability of Repeated Doses of Intravitreal Administration of Two VEGF Trap Formulations in Subjects With Neovascular Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00383370 - Active, not recruiting
Neovascular Age Related Macular Degeneration
- Safety Study of 16.5mg (3.3%) CGC-11047 Injected Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00446654 - Active, not recruiting
Age Related Macular Degeneration
- A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00569140 - Recruiting
Age-Related Macular Degeneration
- A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00395057 - Recruiting
Choroid Neovascularization; Age-Related Macular Degeneration
- The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
ClinicalTrials.gov Identifier: NCT00485394 - Recruiting
Age-Related Macular Degeneration
- Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00517010 - Recruiting
Age-Related Macular Degeneration
- Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00423189 - Recruiting
Age-Related Macular Degeneration
- Fundus Autofluorescence Imaging in Age-Related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
ClinicalTrials.gov Identifier: NCT00393692 - Recruiting
Age-Related Macular Degeneration
- Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00473928 - Recruiting
Age-Related Macular Degeneration
- A Study to Evaluate Retisert in the Treatment of Patients with the "wet" form of Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00032396 - Active, not recruiting
Macular Degeneration
- Extension Study of rhuFab V2 in Subjects with Neovascular Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00095433 - Active, not recruiting
Macular Degeneration
- Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00329277 - Recruiting
Age-Related Macular Degeneration
- Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00443911 - Recruiting
Age-Related Macular Degeneration
- Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Monotherapy - Intravitreal Ranibizumab Alone to Treat Age-Related Macular Degeneration.
ClinicalTrials.gov Identifier: NCT00390208 - Active, not recruiting
Age Related Macular Degeneration
- A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00251459 - Active, not recruiting
Choroidal Neovascularization; Age-Related Macular Degeneration
- Age-Related Macular Degeneration and Cataract
ClinicalTrials.gov Identifier: NCT00001312 - Active, not recruiting
Cataract; Macular Degeneration
- Study of Sirna-027 in Patients With Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00495742 - Active, not recruiting
Macular Degeneration; Choroidal Neovascularization
- An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD.
ClinicalTrials.gov Identifier: NCT00058994 - Active, not recruiting
Macular Degeneration; Maculopathy, Age-Related
- Anecortave Acetate in Patients With Exudative Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00299507 - Active, not recruiting
Macular Degeneration
- SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00331864 - Active, not recruiting
Age-Related Macular Degeneration; Choroidal Neovascularization
- Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00259753 - Active, not recruiting
Macular Degeneration
- Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00347399 - Recruiting
Age Related Macular Degeneration
- Changes in Retinal Function After Intravitreal Ranibizumab for Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00539734 - Recruiting
Age-Related Macular Degeneration
- A Study of the Safety and Efficacy of an Investigational Drug in Subjects with Subfoveal Choroidal Neovascularization Associated with Age-related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00090532 - Completed
Age-Related Macular Degeneration
- Safety and Tolerability of Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Neovascular Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00320775 - Active, not recruiting
Macular Degeneration
- Treatment of Age-Related Macular Degeneration With Anecortave Acetate
ClinicalTrials.gov Identifier: NCT00211458 - Active, not recruiting
Macular Degeneration
- Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00078221 - Active, not recruiting
Macular Degeneration
- Improving Function in Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00572039 - Enrolling by invitation
Age-Related Macular Degeneration
- Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00320788 - Active, not recruiting
Macular Degeneration
- Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00157976 - Recruiting
Macular Degeneration
- Genetic Factors in Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00058695 - Recruiting
Macular Degeneration
- OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00306488 - Recruiting
Bilateral Geographic Atrophy; Age-Related Macular Degeneration; AMD
- Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00140803 - Completed
Age-Related Macular Degeneration
- Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
ClinicalTrials.gov Identifier: NCT00148551 - Active, not recruiting
Age-Related Macular Degeneration
- Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00414206 - Recruiting
Macular Degeneration
- A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00454389 - Recruiting
Macular Degeneration
- Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
ClinicalTrials.gov Identifier: NCT00346060 - Recruiting
Dry Age Related Macular Degeneration.
- Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
ClinicalTrials.gov Identifier: NCT00324116 - Recruiting
Macular Degeneration
- A Study on the Efficacy of Macugen Injections in Patients With Neovascular Age-Related Macular Degeneration in Real Life.
ClinicalTrials.gov Identifier: NCT00549055 - Not yet recruiting
Neovascular Age-Related Macular Degeneration
- Clinical Study Of EYE001 For Wet-Type Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00239928 - Recruiting
Macular Degeneration
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00304954 - Recruiting
Macular Degeneration; Neovascularization
- Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00460408 - Recruiting
Macular Degeneration
- Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00395707 - Recruiting
Macular Degeneration
- Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00504959 - Active, not recruiting
Subfoveal Choroidal Neovascularization (CNV); Secondary to Age-Related Macular Degeneration (AMD)
- Combination Therapy for Neovascular Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00447031 - Recruiting
Macular Degeneration
- Oxidative Stress in Patients With Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00465400 - Recruiting
Macular Degeneration
- Systemic Avastin Therapy in Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00531024 - Recruiting
Macular Degeneration
- Intravitreal Bevacizumab for Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00347165 - Recruiting
Age Related Macular Degeneration
- Combination Therapy for Age-Related Macular Degeneration.
ClinicalTrials.gov Identifier: NCT00376701 - Recruiting
Age Related Macular Degeneration
- The Role of Macular Pigment in Patients With Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00494325 - Recruiting
Age Related Maculopathy
- Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00541333 - Not yet recruiting
Dry Age Related Macular Degeneration
- Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)
ClinicalTrials.gov Identifier: NCT00000167 - Completed
Macular Degeneration
- Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
ClinicalTrials.gov Identifier: NCT00150202 - Completed
Macular Degeneration
- Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00100009 - Completed
Macular Degeneration
- Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00288561 - Completed
Age-Related Macular Degeneration (ARMD)
- Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
ClinicalTrials.gov Identifier: NCT00305630 - Completed
Choroidal Neovascularization; Age-Related Macular Degeneration
- The Effect of Eggs and Egg Products on the Macular Pigment
ClinicalTrials.gov Identifier: NCT00527553 - Enrolling by invitation
Age-Related Macular Degeneration
- Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00470678 - Active, not recruiting
Choroidal Neovascularization; Macular Degeneration
- Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00211419 - Active, not recruiting
Maculopathy, Age-Related
- High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00277784 - Completed
Age Related Macular Degeneration
- Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00429936 - Recruiting
Macular Degeneration; Atrophy
- Open-Label, Long-Term, Safety and Tolerability Study of Intravitreal VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00527423 - Not yet recruiting
Macular Degeneration
- Copaxone in Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00466076 - Recruiting
Macular Degeneration
- Investigating Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00342251 - Recruiting
Age-Related Macular Degeneration
- Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00556348 - Completed
Age Related Macular Degeneration
- Age-Related Eye Disease Study (AREDS)
ClinicalTrials.gov Identifier: NCT00000145 - Active, not recruiting
Macular Degeneration; Cataract; Lens Opacities
- Reduced Fluence PDT With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00473642 - Recruiting
Age-Related Maculopathy; Choroidal Neovascularization
- Age-Related Eye Disease Study 2 (AREDS2)
ClinicalTrials.gov Identifier: NCT00345176 - Recruiting
Age-Related Macular Degeneration
- Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00503022 - Completed
Wet Age-Related Macular Degeneration
- Pegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age-related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00087763 - Completed
Macular Degeneration
- Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00215670 - Completed
Age-Related Macular Degeneration
- Selective RPE Laser Treatment (SRT) for Various Macular Diseases
ClinicalTrials.gov Identifier: NCT00403884 - Recruiting
Age-Related Macular Degeneration; Diabetic Maculopathy; Central Serous Chorioretinopathy
- Age-Related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
ClinicalTrials.gov Identifier: NCT00417846 - Active, not recruiting
Maculopathy, Age-Related; Choroidal Neovascularization
- Investigation of Macular Pigment Augmentation on Dark Adaptation
ClinicalTrials.gov Identifier: NCT00478439 - Not yet recruiting
Aging; Age-Related Macular Degeneration
- Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00220805 - Completed
Macular Degeneration
- PDT Vs TTT in Occult CNV in AMD
ClinicalTrials.gov Identifier: NCT00347906 - Active, not recruiting
Age-Related Macular Degeneration
- Intravitreous Pegaptanib Sodium Injection in patients with Exudative Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00088192 - Completed
Macular Degeneration
- TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00464347 - Terminated
Age-Related Macular Degeneration
- A Study of rhuFab V2 (ranibizumab) in Subjects with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00090623 - Completed
Macular Degeneration
- Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov Identifier: NCT00109499 - Completed
Macular Degeneration
- Genetic Study of Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00357578 - Completed
Age-Related Macular Degeneration
- Lutein for Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00006202 - Completed
Macular Degeneration
- A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) to Treat "Wet" Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00139282 - Terminated
"Wet" Age-Related Macular Degeneration
- Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00284089 - Completed
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-Related Macular Degeneration (AMD)
- PDT Study for Exudative AMD With PCV
ClinicalTrials.gov Identifier: NCT00331435 - Recruiting
Age-Related Macular Degeneration
- Prophylactic Laser Treatment of Drusen Maculopathy
ClinicalTrials.gov Identifier: NCT00348543 - Recruiting
Age-Related Macular Degeneration
- CAPTAIN:CNV Assessment by Pattern Electroretinography
ClinicalTrials.gov Identifier: NCT00500344 - Recruiting
Age-Related Macular Degeneration
- Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV
ClinicalTrials.gov Identifier: NCT00429962 - Active, not recruiting
Choroidal Neovascularization; Age-Related Macular Degeneration
- Ultrasonic Evaluation of Ocular Tissues
ClinicalTrials.gov Identifier: NCT00279695 - Recruiting
Glaucoma; Tumors; Age-Related Macular Degeneration
- Efficacy of Retreatments With Intravitreal Bevacizumab
ClinicalTrials.gov Identifier: NCT00406744 - Recruiting
Age Related Macular Degeneration; Choroidal Neovascularization
- The Zeaxanthin and Visual Function Study
ClinicalTrials.gov Identifier: NCT00564902 - Recruiting
Age Related Macular Degeneration; Cognition Disorders
- A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
ClinicalTrials.gov Identifier: NCT00556114 - Enrolling by invitation
Retina; Glaucoma; Diabetic Retinopathy; Age-Related Macular Degeneration
- A 7-Month Study of the Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-VEGF Treatment in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00511706 - Recruiting
Choroidal Neovascularization; Age-Related Maculopathy
- Subretinal Lucentis for Hemorrhagic AMD
ClinicalTrials.gov Identifier: NCT00538538 - Recruiting
Retinal Hemorrhage; Neovascular Age Related Macular Degeneration
- Stratus Versus Cirrus OCT in AMD
ClinicalTrials.gov Identifier: NCT00568191 - Recruiting
Age-Related Macular Degeneration; Choroidal Neovascularization
- Retaane® in Age-Related Macular Degeneration
ClinicalTrials.gov Identifier: NCT00569569 - Completed
Age Related Macular Degeneration
Resources
- Age-Related Macular Degeneration (National Institutes of Health)
- Age-Related Macular Degeneration: What You Should Know (National Eye Institute)
email this page
print this page
bookmark this page
feedback on this page
